Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tocilizumab in systemic sclerosis (faSScinate)
NCT01532869Phase 3Completed
- Sponsor
- Roche
- Start
- Mar 2012
- Primary completion
- Jan 2014
- Modality
- Antibody Conjugates, Recombinant Proteins and Enzymes, Engineered Antibody Formats
- Countries
- 5
01
Overview
A Phase 3 trial of tocilizumab in systemic sclerosis (SSc), sponsored by Roche. Started Mar 2012; status: completed.
02
Drugs
tocilizumab
03
Conditions
systemic sclerosis (SSc)
Beyond the preview
Go deeper on NCT01532869.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01532869.